Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.
Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.
Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.
Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.
Health Catalyst, a provider of data and analytics technology for healthcare, reported third-quarter 2022 results showing an 11% revenue increase year-over-year to $68.35 million. The company exceeded guidance for revenue and Adjusted EBITDA, with technology revenue rising 15% to $44 million. Adjusted EBITDA improved by 21%, showcasing operational efficiency. Health Catalyst also raised its full year 2022 revenue and Adjusted EBITDA guidance, expecting a dollar-based retention level between 97% and 101%. These results reflect strong client expansion and effective cost-reduction strategies.
Health Catalyst (Nasdaq: HCAT) announces that its KPI Ninja solution has received NCQA Certification for HEDIS® Measures for the third consecutive year. This certification validates KPI Ninja's measure logic for accurate patient data results, supporting Health Information Exchanges (HIEs) in transitioning to value-based care. The achievement demonstrates KPI Ninja's ongoing commitment to quality measures, essential for healthcare organizations aiming for enhanced population health outcomes. The certification reinforces Health Catalyst's reputation as a leading provider of data and analytics technology in healthcare.
Health Catalyst, Inc. (Nasdaq: HCAT) will release its Q3 2022 operating results on November 8, 2022, after market close. Following the release, a conference call for analysis will occur at 5 p.m. E.T. Participants can join by dialing (800) 225-9448 for U.S. calls or (203) 518-9708 internationally, using conference ID “HCAT Q322.” The call will also be available via a live audio webcast. Health Catalyst focuses on providing data and analytics services to healthcare organizations, leveraging a cloud-based platform analyzing over 100 million patient records to drive healthcare improvements.
On September 14, 2022, Health Catalyst (HCAT) announced the winners of its fourth annual Catalyst Awards during the Healthcare Analytics Summit 2022. The awards honor healthcare organizations for their outstanding use of data and analytics. The University of Kansas Health System received the Flywheel Award for its significant healthcare improvements, including $4.7 million in cost savings and a 39% reduction in 30-day readmissions. Other winners included INTEGRIS Health, WakeMed Health and Hospitals, Indiana University Health, and UnityPoint Health, each recognized for their innovative practices in analytics and patient care.
On September 7, 2022, Health Catalyst (Nasdaq: HCAT) announced new leadership appointments to strengthen its strategic focus areas. Kevin Freeman has been named Chief Growth Officer, while Tarah Neujahr Bryan becomes Chief Marketing Officer. Both will prioritize expanding client relationships. Dave Ross is appointed Chief Technology Officer to enhance data and analytics infrastructure. Effective September 30, 2022, Patrick Nelli transitions to Senior Advisor, and Bryan Hinton completes his tenure. CEO Dan Burton highlighted these changes as pivotal for the company's mission of data-informed healthcare improvements.
Health Catalyst (Nasdaq: HCAT) announced that its CFO, Bryan Hunt, and SVP of Investor Relations, Adam Brown, will participate in the Canaccord Genuity 42nd Annual Growth Conference in Boston on August 11, 2022. They will engage in a fireside chat at 12:00pm ET. The presentation replay will be available on Health Catalyst's investor relations website.
Health Catalyst specializes in data and analytics solutions for healthcare organizations, driven by insights from over 100 million patient records to enhance healthcare decision-making.
Health Catalyst, Inc. (NASDAQ: HCAT) announced the addition of Dr. Melissa Welch as Chief Medical Officer and Dr. Edward Sheen as Chief Population Health Officer. Dr. Welch will support client growth and healthcare improvements, while Dr. Sheen will lead value-based care initiatives. Both new leaders are dedicated to advancing Health Catalyst's mission of data-informed healthcare improvements. Their combined experience in public health and healthcare systems is expected to enhance the company's capabilities and impact in the healthcare sector.
Health Catalyst (Nasdaq: HCAT) announced a $40 million share repurchase program, highlighting their confidence in long-term value. CEO Dan Burton stated the current market does not reflect their true stock value. Repurchases will be discretionary based on market conditions and funded by existing cash, estimated at $403.3 million as of June 30, 2022. The program aims to enhance shareholder value while allowing flexibility in buying patterns.
Health Catalyst (Nasdaq: HCAT) reported Q2 2022 financial results, achieving total revenue of $70.6 million, an 18% year-over-year increase. Technology revenue rose 28% to $45.4 million, while professional services revenue grew 5% to $25.2 million. Despite this, the company revised its full-year revenue and Adjusted EBITDA outlook downwards due to a challenging market environment impacting bookings. However, Health Catalyst remains focused on financial discipline and expects improved Adjusted EBITDA leverage in 2023.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
